Loading…
MEDIROM Healthcare Technologies Inc. is projected to decline to $1.05 by 2027, a -12% move from its current price of $1.20. MRM is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.13 | $1.20 | $1.28 | -0.02% |
| May 30 | $1.10 | $1.20 | $1.31 | -0.05% |
| May 31 | $1.08 | $1.20 | $1.34 | -0.07% |
| Jun 1 | $1.06 | $1.20 | $1.36 | -0.09% |
| Jun 2 | $1.04 | $1.20 | $1.38 | -0.12% |
| Jun 3 | $1.03 | $1.20 | $1.40 | -0.14% |
| Jun 4 | $1.01 | $1.20 | $1.41 | -0.17% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.01 | $1.20 | $1.41 | -0.17% |
| Week 2 | $0.946 | $1.20 | $1.51 | -0.33% |
| Week 3 | $0.8959 | $1.19 | $1.59 | -0.50% |
| Week 4 | $0.8555 | $1.19 | $1.66 | -0.66% |
| Week 5 | $0.8213 | $1.19 | $1.72 | -0.83% |
| Week 6 | $0.7915 | $1.19 | $1.78 | -0.99% |
| Week 7 | $0.7648 | $1.19 | $1.84 | -1.16% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
MEDIROM Healthcare Technologies Inc., together with its subsidiaries, provides holistic health services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty.
The Relaxation Salon segment develops, owns, operates, franchises, and supports relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. This segment operates relaxation salons under the Re.Ra.Ku and Ruam Ruam brands.
The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program that utilizes Lav, an on-demand health monitoring smartphone application, as well as MOTHER Bracelet for fitness and health applications; and provides preventative healthcare services utilizing nutritionists and health nurses. The Luxury Beauty segment manages and operates hair salons under the ZACC brand name. The company also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques.
The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
MRM is the stock ticker for MEDIROM Healthcare Technologies Inc., a consumer cyclical company.
A major floor 36.1% below — a decisive break under it would weaken the trend.
The nearest floor, 24.2% below — buyers have tended to step in here.
The nearest ceiling, 5.8% above — a clean break opens room to run.
A major ceiling 45.8% above — clearing it would confirm fresh momentum.
Key MRM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MRM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.11 | Buy | $1.13 | Buy |
| MA 10 | $1.02 | Buy | $1.09 | Buy |
| MA 20 | $1.09 | Buy | $1.09 | Buy |
| MA 50 | $1.13 | Buy | $1.16 | Buy |
| MA 100 | $1.32 | Sell | $1.32 | Sell |
| MA 200 | $1.69 | Sell | $1.51 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 56.68 | Neutral |
| Stoch RSI (14) | 82.75 | Sell |
| CCI (20) | 64.88 | Neutral |
| Williams %R (14) | -19.44 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 7.14 | Buy |
| Bollinger %B (20,2) | 0.73 | Neutral |
| Stochastic %K (14) | 80.56 | Sell |
| TRIX (15) | -0.50 | Sell |
| Awesome (5,34) | -0.02 | Sell |
| Ultimate (7,14,28) | 62.57 | Neutral |
| Momentum (10) | 0.17 | Buy |
| Aroon Osc (25) | 24.00 | Buy |
| Hull MA (9) | 1.23 | Sell |
| ADX (14) | 22.84 | Buy |
| ATR (14) | 0.06 | Info |
The sentiment is BULLISH with RSI14 at 60. The price is $1.27, with the SMA50 at $1.14 and the SMA200 at $1.70. The stock faces resistance at $1.27 and support at $0.91. The 30-day range runs from $0.8345 to $1.93, reflecting notable near-term volatility.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.91 | $1.20 | $1.46 | 0% | Neutral | |
| $0.7574 | $1.05 | $1.58 | -12% | Neutral | |
| $0.6446 | $0.9505 | $1.52 | -21% | Bearish | |
| $0.6299 | $0.9777 | $1.64 | -19% | Bearish | |
| $0.9293 | $1.51 | $2.64 | +26% | Bullish | |
| $0.8625 | $1.47 | $2.64 | +22% | Bullish | |
| $0.6911 | $1.22 | $2.28 | +2% | Neutral | |
| $0.691 | $1.28 | $2.44 | +6% | Neutral | |
| $0.607 | $1.17 | $2.28 | -3% | Neutral | |
| $0.6787 | $1.35 | $2.71 | +13% | Neutral | |
| $0.6599 | $1.47 | $3.23 | +22% | Bullish | |
| $1.40 | $3.11 | $7.14 | +159% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.91 | $1.20 | $1.41 | +0.00% |
| June 2026 | $0.9838 | $1.18 | $1.47 | -1.68% |
| July 2026 | $0.9628 | $1.17 | $1.50 | -0.48% |
| August 2026 | $0.8742 | $1.08 | $1.40 | -7.98% |
| September 2026 | $0.8365 | $1.05 | $1.38 | -3.25% |
| October 2026 | $0.8833 | $1.12 | $1.49 | +6.69% |
| November 2026 | $0.8822 | $1.12 | $1.52 | +0.78% |
| December 2026 | $0.8303 | $1.07 | $1.46 | -5.06% |
Click any year to see its month-by-month MRM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, MRM could reach as high as $1.46, with a base case around $1.20 and support toward $0.91 — roughly 0% from $1.20. A consolidation phase looks the most probable path here.
Expect MRM to range from $0.7574 to $1.58 through 2027. The $1.05 average target implies a -12% move from current prices. That is -12% versus the projected 2026 average. Price action looks broadly range-bound.
The MRM price prediction for 2028 points to an average of $0.9505 (low $0.6446, high $1.52) — a potential decline of -21% on today's $1.20. Expect choppier, lower action through this leg of the cycle.
In 2029, MRM is projected to trade between $0.6299 and $1.64, averaging $0.9777 — a potential decline of -19% from today's $1.20. That is up +3% on the projected 2028 average. A cyclical pullback looks likely — prices rarely move in a straight line.
MEDIROM Healthcare Technologies Inc.'s 2030 outlook centres on $1.51, within a $0.9293 to $2.64 range. That is up +55% on the projected 2029 average. That marks a +26% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, MRM could reach as high as $2.64, with a base case around $1.47 and support toward $0.8625 — roughly +22% from $1.20. Momentum favours further upside here.
Expect MRM to range from $0.6911 to $2.28 through 2032. The $1.22 average target implies a +2% move from current prices. That is -16% versus the projected 2031 average. A consolidation phase looks the most probable path here.
The MRM price prediction for 2033 points to an average of $1.28 (low $0.691, high $2.44) — a potential gain of +6% on today's $1.20. Price action looks broadly range-bound.
In 2034, MRM is projected to trade between $0.607 and $2.28, averaging $1.17 — a potential decline of -3% from today's $1.20. That is -9% versus the projected 2033 average. A consolidation phase looks the most probable path here.
MEDIROM Healthcare Technologies Inc.'s 2035 outlook centres on $1.35, within a $0.6787 to $2.71 range. That is up +16% on the projected 2034 average. That marks a +13% change versus current levels. Price action looks broadly range-bound.
By 2040, MRM could reach as high as $3.23, with a base case around $1.47 and support toward $0.6599 — roughly +22% from $1.20. Buyers look set to stay in control over this stretch.
Expect MRM to range from $1.40 to $7.14 through 2050. The $3.11 average target implies a +159% move from current prices. That is up +112% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in MRM today (≈ 833.333333 MRM) could be worth
$2,588.51
+$1,588.51 (+159%) by 2050 · US Dollar
Based on the average projected MRM price of $3.11 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MRMwould be worth at today's price.
$1,000 invested in MRM on May 27, 2025 (≈ 709.219875 MRM) would be worth
$851.06
-$148.94 (-14.9%) today · 0.85× · US Dollar
Based on a MRM entry price of $1.41 vs. today's $1.2.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.92 | $1,304.35 | +30.4% |
| 1 month ago | $1.16 | $1,034.48 | +3.4% |
| 3 months ago | $1.45 | $829.88 | -17.0% |
| 6 months ago | $2.03 | $591.13 | -40.9% |
| 1 year ago | $1.41 | $851.06 | -14.9% |
| All time (5.0y) ago | $9.89 | $121.33 | -87.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MRM forecast.
Our base-case forecast reaches $2.40 around 2050.
Implied market cap at $2.40: $18.96M
The multi-year forecast shows a bullish path in the long run. For 2030, the average price is $1.62 with a max of $2.83 and a min of $0.9979, yielding a 27.9% ROI and a bullish sentiment. In 2040, the average is $1.53 with a max of $3.36 and a min of $0.6881, with a 20.4% ROI and a bullish sentiment.
By 2050, the average reaches $3.29 with a max of $7.56 and a min of $1.48, delivering a 158.8% ROI and a bullish sentiment.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $1.62, a min of $0.9979, and a max of $2.83, with a 27.9% ROI and a bullish sentiment.
Forecasts show neutral sentiment in 2026, with an average price of $1.27 and ROI of 0%, followed by neutral in 2027 (avg $1.12, ROI -12%), and bear years in 2028 (avg $1.00, ROI -21.2%) and 2029 (avg $1.05, ROI -17.4%). The outlook turns bullish from 2030 onward, with stronger upside in 2040 and especially 2050.
Yes, the forecast for 2050 lists a max of $7.56, with a bullish long-term outlook, though actual results may vary and are not guaranteed.
Current price is $1.27 and market cap is $10.04M.
The 30-day range is from $0.8345 to $1.93.
MEDIROM Healthcare Technologies Inc. Community Discussion
0Share your MEDIROM Healthcare Technologies Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.